News

We are proud to announce that AstaReal® – Fuji Chemical Industries has been awarded the Editor’s Award for Infant and Child Nutrition Initiative at the NutraIngredients-Asia Awards 2025 🏆

This year’s award recognizes the pioneering achievement of Fuji Chemical / AstaReal Group in conducting the world’s first astaxanthin clinical study in children aged 10-14, demonstrating the potential of AstaReal® Astaxanthin to support digital eye strain in developing eyes. This innovative research represents a significant milestone in pediatric eye health and astaxanthin science.

We also invite you to view the interview video and article published on NutraIngredients-Asia.

This recognition is the result of months of dedicated research, cross-functional collaboration, and an unwavering commitment to scientific excellence. It also reflects the strength of our legacy — 37 years of continuous dedication to advancing health and wellness worldwide.

This marks our third win, following previous recognitions in 2022 and 2023 — a testament to our continued leadership in the nutraceutical field. Our work in Natural Astaxanthin continues to push boundaries, and this award further highlights the originality and global impact of our research.

We extend our heartfelt thanks to our passionate team, trusted partners, and loyal customers.
Together, we will continue driving innovation in the nutraceutical industry.

For more information about this research and to develop your next best formulation for kids with AstaReal,
please feel free to contact us.